The FDA has approved the drug Ekterly (sebetralstat) for acute HAE attacks — the first treatment option that doesn’t require an injection or infusion. The U.S. Food and Drug Administration (FDA) has ...

Please provide your email address to receive an email when new articles are posted on . Children took daily doses of berotralstat that ranged from 78 mg to 150 mg. There were no grade 3 or 4 adverse ...

In the rare disease hereditary angioedema, or HAE, painful swelling attacks can happen anywhere in the body without warning. Drugs are available for acute treatment of these attacks, but they’re all ...